RE: Promising response"It has been shown to work in animals with different cancers,"
At the mean time, BNC should start promoting Urocidin on other animals' cancers applications which can come to market faster than human FDA approvals. It can help generate some revenue, serve as a precurser model for other human cancer uses and also generate public's notice on the potential of Urocidin and put pressure on FDA to a speedy approval.
Very good quote, indeed.
Our next battle is to fight off this bottom-fishing mentality. Even from some of our current holders. This practice gives the day-traders room to short our stock price and also kill off any rally. Should we be that greedy just to make a few pennies profit and end up markedly postponing any rally?
Like anything, great profit takes time. Our patience will be handsomely rewarded. Hang in there folks.